ResultsIQ

ResultsIQ › Latest results › Medi Assist Healthcare Services Limited

Medi Assist Healthcare Services Limited Q1 FY26 earnings call summary

NSE: MEDIASSIST · BSE: 544088

Earnings call of 7 Aug 2025, summarised by AI from the filing.

Medi Assist Q1 FY26 total income ₹198 cr, up 14.5%; Paramount acquisition closed for ₹412.4 cr, consolidation from Q2.

Key takeaways

  1. Risk Underlying softness in group same-store growth due to slower lives growth; Paramount consolidation to impact margins.

Original filing on BSE

Medi Assist Healthcare Services Limited Q1 FY27 results

As filed: Revenue ₹237 cr (+24% year on year), EBITDA ₹48.0 cr (+12% year on year), PAT ₹27.6 cr (+20% year on year), EBITDA margin 20.3% (−221 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹242 cr (+28% year on year), EBITDA ₹48.3 cr (+21% year on year), PAT ₹54.5 cr (+148% year on year), EBITDA margin 19.9% (−123 bps). Score 78 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin fell 123 bps year on year. Tax rate -95%. Revenue rose ₹53.0 cr on a year ago, more than the ₹22.0 cr it added the year before. Share price after the results: −7.2% in 30 days (Nifty 500: −4.1%).
  • Q3 FY26: Revenue ₹240 cr (+29% year on year), EBITDA ₹44.6 cr (+14% year on year), PAT ₹4.1 cr (−16% year on year), EBITDA margin 18.6% (−235 bps). Score 44 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit before exceptional items growth was below it. EBITDA margin fell 235 bps year on year. Other income 89% of PBT. Tax rate 51%. Consolidated profit -86% but standalone +196%. Revenue rose ₹53.7 cr on a year ago, more than the ₹20.0 cr it added the year before. Share price after the results: −19.9% in 28 days (Nifty 500: −4.1%).
  • Q2 FY26: Revenue ₹233 cr (+29% year on year), EBITDA ₹40.0 cr (+3% year on year), PAT ₹8.0 cr (−62% year on year), EBITDA margin 17.2% (−438 bps). Score 29 of 100, Below trend. EBITDA margin fell 438 bps year on year. Tax rate 38%. Consolidated profit -62% but standalone +80%. Not enough history for a trend yet: scored on growth alone. Profit fell 65% from last quarter. Share price after the results: −15.6% in 30 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹191 cr (+14% year on year), EBITDA ₹43.0 cr (+19% year on year), PAT ₹23.0 cr (+21% year on year), EBITDA margin 22.5% (+108 bps). Score 57 of 100, In line with trend. EBITDA margin rose 108 bps year on year. Consolidated profit +21% but standalone -11%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −4.8% in 29 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹189 cr (+13% year on year), EBITDA ₹40.0 cr (+8% year on year), PAT ₹22.0 cr (−15% year on year), EBITDA margin 21.2% (−99 bps). Score 32 of 100, Below trend. EBITDA margin fell 99 bps year on year. Other income 27% of PBT. Not enough history for a trend yet: scored on growth alone. Profit fell 27% from last quarter. Share price after the results: +13.4% in 29 days (Nifty 500: +6.1%).
  • Q3 FY25: Revenue ₹186 cr (+12% year on year), EBITDA ₹39.0 cr (+15% year on year), PAT ₹30.0 cr (+43% year on year), EBITDA margin 21.0% (+49 bps). Score 54 of 100, In line with trend. EBITDA margin rose 49 bps year on year. Tax rate -11%. Consolidated profit +43% but standalone -20%. Not enough history for a trend yet: scored on growth alone.
  • Q2 FY25: Revenue ₹181 cr, EBITDA ₹39.0 cr, PAT ₹21.0 cr, EBITDA margin 21.6%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹181 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

Medi Assist Healthcare Services Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.